The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy

Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum), Guy A. Rouleau(Douglas Mental Health University Institute), Jorge Sequeiros(Universidade do Porto), Roy Zaltzman(Tel Aviv University), Marcondes C. França(National Hospital for Neurology and Neurosurgery), Gunnar Blumenstock(University of Tübingen), Bart P.C. van de Warrenburg(Radboud University Nijmegen), Laura Bannach Jardim(Universidade Federal do Rio Grande do Sul), Sandra Martins(Universidade do Porto), Chrisovalantou Huridou(University of Tübingen), Alexandra Dürr(Institut du Cerveau), Alexis Brice(School of the Art Institute of Chicago), N Schwarz(University of Tübingen), Priscila Pereira Sena(University of Tübingen), Rana Dilara Incebacak Eltemur(University of Tübingen), Daniel Weishäupl(University of Tübingen), Olaf Rieß(STZ eyetrial), Lüdger Schöls(German Center for Neurodegenerative Diseases), Miriam Döcker(University of Tübingen), Maria Luiza Saraiva Pereira(Universidade Federal do Rio Grande do Sul), Florian Fath(University of Tübingen), Peter Bauer(Centogene (Germany)), Carlos R. Gordon(Tel Aviv University), Leah Czisch(University of Tübingen), Anna Würth(University of Tübingen), Mario Cornejo‐Olivas(Universidad Científica del Sur), Thomas Klockgether(University Hospital Bonn)
Acta Neuropathologica
August 1, 2024
Cited by 8


Related Papers